Tate & Lyle Rating Reiterated by Credit Suisse (TATE)
Tate & Lyle (LON:TATE)‘s stock had its “neutral” rating reaffirmed by equities researchers at Credit Suisse in a research report issued on Thursday, Stock Ratings Network reports. They currently have a GBX 800 ($13.12) price objective on the stock. Credit Suisse’s target price suggests a potential upside of 3.49% from the company’s current price.
Other equities research analysts have also recently issued reports about the stock. Analysts at Canaccord Genuity reiterated a “buy” rating on shares of Tate & Lyle in a research note to investors on Tuesday. They now have a GBX 900 ($14.76) price target on the stock. Separately, analysts at Galvan Research reiterated a “buy” rating on shares of Tate & Lyle in a research note to investors on Monday, December 23rd. They now have a GBX 840 ($13.78) price target on the stock. Finally, analysts at Berenberg Bank reiterated a “buy” rating on shares of Tate & Lyle in a research note to investors on Tuesday, December 10th. They now have a GBX 900 ($14.76) price target on the stock. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and nine have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of GBX 863.27 ($14.16).
Tate & Lyle (LON:TATE) opened at 766.345 on Thursday. Tate & Lyle has a one year low of GBX 730.50 and a one year high of GBX 889.5001. The stock has a 50-day moving average of GBX 792.3 and a 200-day moving average of GBX 801.1. The company’s market cap is £3.558 billion.
Tate & Lyle PLC is a provider of speciality food ingredients and solutions. The Company and its subsidiary and associated undertakings together with its joint ventures develops, manufactures and markets food and industrial ingredients made from renewable resources.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.